Indication
Atropine
1 clinical trial
2 products
Clinical trial
A Two-Period, Two-Sequence, Two-Treatment, Single-Dose Crossover Study of Atropine Sulfate Ophthalmic Solution (1%) Administered Sublingually vs Atropine Sulfate Administered Intramuscularly for Bioequivalence DeterminationStatus: Not yet recruiting, Estimated PCD: 2024-05-24
Product
Atropine Sulfate